P-316 TP53 mutations in patients with myelodysplastic syndrome and isolated deletion (5q) treated with lenalidomide: Results from the German Le-Mon-5 trial

✍ Scribed by Mossner, M.; Platzbecker, U.; Giagounidis, A.; Götze, K.; Letsch, A.; Haase, D.; Schlenk, R.; Bug, G.; Lübbert, M.; Ganser, A.; Jann, J.C.; Obländer, J.; Fey, S.; Hofmann, W.K.; Germing, U.; Nolte, F.

• Book ID: 122967509
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 68 KB
• Volume: 37
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/S0145-2126(13)70363-1